Last reviewed · How we verify
Smoking cessation assistance
Approved treatments
- Wellbutrin · GSK (GlaxoSmithKline)
Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects. - Nicorette · Sanofi
- Tabex · Pfizer
- Chantix · Pfizer
Chantix works by activating the brain's nicotinic receptors, reducing cravings and the pleasurable effects of smoking. - Wellbutrin · Mclean Hospital
- Champix · The Queen Elizabeth Hospital
- Elontril · Boehringer Ingelheim
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Smoking cessation assistance patent landscape — cliff calendar, originator estates, attackable patents
- Smoking cessation assistance treatment landscape brief
- Smoking cessation assistance treatment updates RSS
Frequently asked questions about Smoking cessation assistance
What drugs treat Smoking cessation assistance?
Tracked treatments include Wellbutrin, Nicorette, Tabex, Chantix, Champix, Elontril.
What is the treatment for Smoking cessation assistance?
Standard treatment for Smoking cessation assistance includes Wellbutrin, Nicorette, Tabex, Chantix, Champix. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Smoking cessation assistance patent cliff · Smoking cessation assistance CI report
- Treatment: Wellbutrin · GSK (GlaxoSmithKline)
- Treatment: Nicorette · Sanofi
- Treatment: Tabex · Pfizer
- Treatment: Chantix · Pfizer
- Treatment: Wellbutrin · Mclean Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing